Dublin, April 14, 2026 (GLOBE NEWSWIRE)-- The "APIs in Focus: Understanding ICH, GMP and Supply Chain Excellence (Apr 29th - Apr 30th, 2026)" training has been added to ResearchAndMarkets.com's ...
Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients Directory" directory has been added to ResearchAndMarkets.com's offering. Published annually the Active Pharmaceutical ...
DUBLIN, May 10, 2021 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredient Market (2020-2025) by Type, Molecule, Product Type, Formulation Type, Manufacturing Type, Synthesis Type, Drug Type, ...
DUBLIN--(BUSINESS WIRE)--The "Active Pharmaceutical Ingredients (APIs) Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering. The global active ...
The "Understanding Active Pharmaceutical Ingredients (APIs) Training Course (Apr 29th - Apr 30th, 2026)" training has been added to ResearchAndMarkets.com's offering. An active pharmaceutical ...
Dublin, May 08, 2026 (GLOBE NEWSWIRE)-- The "Active Pharmaceutical Ingredient Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F" has been added to ...
Teva Pharmaceuticals plans to remove 250 jobs at its CDMO unit over the next two years, Israeli business news outlet Globes ...
Biologics Active Pharmaceutical Ingredient (API) Market · GlobeNewswire Inc. The biologics active pharmaceutical ingredient (API) market has experienced significant growth in recent years, with ...
IMARC Group’s latest report, titled “Active Pharmaceutical Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, finds that the global active ...
Protein aggregation and active principle ingredients (API) stability are factors that ultimately impact both the usability and quality of many biopharmaceutical products, especially injectables. The ...
TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active ...
Natural active pharmaceutical ingredients – especially biotech-based – are “core buy-and-build terrain” for Astorg, Nicolas Marien, partner, told PE Hub. “The market is fragmented, demand is resilient ...